AFMD
Affimed · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Affimed
Affimed is a biopharmaceutical company that specializes in the development of engineered T-cell engagers for cancer immunotherapy and other therapeutic applications.
| Ticker | AFMD |
| Name | Affimed |
| Currency | USD |
| Sector | Healthcare |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did.
Technical analysis
NEUTRALComputed from 2 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-08 10:25
The stock has shown no significant movement in its most recent close, with a change of -0.0%. Given this lack of momentum and the absence of recent news or market events to influence the price, we are maintaining a cautious stance. The long-term outlook remains uncertain without further information on the company's performance or external factors affecting the stock.
qwen2.5:3b
Related news
- No matched headlines yet.